|
|
EQSNews: Marinomed Biotech AG
/ Key words: Alliance
Marinomed Biotech AG enters Solv4U R&D collaboration with Brazilian pharmaceutical company Aché Laboratórios
25.04.2024 / 07:45 CET/CEST
The issuer is solely responsible for the content of this announcement.
Marinomed Biotech AG ente... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: Marinomed Biotech AG
/ Key words: Annual Results
Marinomed Biotech AG announces results for the 2023 financial year and reports progress with Marinosolv and Carragelose assets
16.04.2024 / 07:45 CET/CEST
The issuer is solely responsible for the content of this announcement.
Marinomed Biote... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: Marinomed Biotech AG
/ Key words: Market Launch
Marinomed Biotech AG: Launch of new allergenblocking Carragelose product in Austria and market entry in Mexico
11.04.2024 / 07:45 CET/CEST
The issuer is solely responsible for the content of this announcement.
Marinomed Biotech AG: Launch of... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: Marinomed Biotech AG
/ Key words: Agreement
Marinomed Biotech AG announces agreement with European Investment Bank EIB to defer repayments of the 2019 venture loan for 18 months
28.03.2024 / 07:45 CET/CEST
The issuer is solely responsible for the content of this announcement.
Marin... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: Marinomed Biotech AG
/ Key words: Contract
Marinomed Biotech AG enters new Carragelose distribution partnerships for Gulf region and Eastern Europe
26.03.2024 / 07:45 CET/CEST
The issuer is solely responsible for the content of this announcement.
Marinomed Biotech AG enters new Carragelose... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: Marinomed Biotech AG
/ Key words: Personnel
Marinomed Biotech AG: Lucia Ziegler new Head of Investor & Public Relations
01.03.2024 / 07:45 CET/CEST
The issuer is solely responsible for the content of this announcement.
Marinomed Biotech AG: Lucia Ziegler new Head of Investo... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: Marinomed Biotech AG
/ Key words: Preliminary Results
Marinomed Biotech AG announces preliminary revenue for 2023
14.02.2024 / 07:45 CET/CEST
The issuer is solely responsible for the content of this announcement.
Marinomed Biotech AG announces preliminary revenue for 2023... Lire le communiqué |
|
| |
|
| |
